Skip to main content

Off-patent Drugs Bill

Question for Department of Health

UIN 17000, tabled on 19 November 2015

To ask the Secretary of State for Health, what discussions his Department has had with the Association of the British Pharmaceutical Industry on the Off-patent Drugs Bill.

Answered on

25 November 2015

The Association of the British Pharmaceutical Industry attended and contributed to the Department’s Roundtable Event of February 2015 ‘Translating evidence in to clinical practice’ which gathered key stakeholders including Breast Cancer Now and other charities, the Medicines and Healthcare products Regulatory Agency, the British Generic Manufacturers Association, the Royal College of Paediatrics and Child Health and many other NHS organisations.